InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Cowan Chad. Director active across 1 company, notably Century Therapeutics, Inc.. Aggregated, 10 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €44k. Activity tracked since 1 October 2024. The latest transaction was disclosed on 1 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Cowan Chad is Chief Scientific Officer at Century Therapeutics, Inc. (XNAS). He has 10 filings in total, and across the 10 sampled filings, the period runs from 2024-10-03 to 2026-06-15, with buys of EUR 42067 and sells of EUR 2371. The most frequent transaction nature shown is tax withholding.